[Cytomegalovirus infections in transplant patients].
Charpentier
B
B
D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D017245:Foscarnet; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D015994:Incidence; D016377:Organ Transplantation / Q000009:adverse effects*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D015774:Ganciclovir
Les infections à cytomégalovirus chez les transplantés.